This inventor holds 5 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignees: Orchid Chemicals & Pharmaceuticals Limited, Orchid Research Laboratories Limited. Active years: 2011-2013.
Company Filing History:

Years Active: 2011-2013
Title: Virendra Kachhadia: Innovator in Histone Deacetylase Inhibitors
Introduction
Virendra Kachhadia is a notable inventor based in Chennai, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of histone deacetylase inhibitors. With a total of 5 patents to his name, Kachhadia's work is pivotal in addressing various diseases related to cellular growth.
Latest Patents
Kachhadia's latest patents focus on novel stilbene-like compounds that serve as histone deacetylase (HDAC) inhibitors. These compounds, described by the general formula (I), include their derivatives, analogs, and various forms. They are designed to inhibit HDACs and are useful as therapeutic agents for diseases such as malignant tumors, autoimmune diseases, skin diseases, infections, and inflammation. Another patent details a method for treating conditions mediated by HDAC, including cancer and psoriasis, by administering an effective amount of these novel compounds.
Career Highlights
Throughout his career, Kachhadia has worked with prominent companies in the pharmaceutical industry. He has been associated with Orchid Chemicals & Pharmaceuticals Limited and Orchid Research Laboratories Limited, where he has contributed to innovative research and development.
Collaborations
Kachhadia has collaborated with notable professionals in his field, including Sriram K Rajagopal and Akella Satya Surya Visweswara Srinivas. These collaborations have further enhanced his research and development efforts.
Conclusion
Virendra Kachhadia's contributions to the field of histone deacetylase inhibitors highlight his innovative spirit and dedication to advancing medical science. His work continues to impact the treatment of various diseases, showcasing the importance of innovation in pharmaceuticals.